Mainz Biomed Provides U.S. Regulatory Review Update for ColoAlert
Pivotal Clinical Trial Pre-Submission Accepted for Review by the U.S. Food & Drug Administration BERKELEY,…
Pivotal Clinical Trial Pre-Submission Accepted for Review by the U.S. Food & Drug Administration BERKELEY,…
LONDON, Feb. 23, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a…
PRESS RELEASE iosBio receives UK grant to develop oral vaccine against Nipah virus Zoonotic virus…
Press Release Nicox Announces VYZULTA Now Commercialized in 7 Territories and Approved in Further 9…
SINGAPORE, Feb. 23, 2022 (GLOBE NEWSWIRE) — a Big Cat Studio’s brainchild named “Dark Land…
NFT Platform New World Inc. Continues to Further Advance Its Augmented Reality Technology Toronto, Ontario–(Newsfile…
Dubai, United Arab Emirates–(Newsfile Corp. – February 23, 2022) – Zex PR Wire is delighted…
LONDON–(BUSINESS WIRE)–#award—Transaction Network Services (TNS) has won ‘Best Managed Services Solutions for Trading’ at the…
Identity verification leader surpasses $100M revenue and 150 million cumulative verifications, adding Volkswagen Financial Services,…
MLSE and AWS will innovate together to deliver more extraordinary moments for fans of Toronto’s…
Milan, Italy–(Newsfile Corp. – February 22, 2022) – Coin of Champions continues to record significant…
Nearly one in three financial reports are manually produced Many decision-makers spend hours on recurring…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical…
Montrouge, France, February 22, 2022 DBV Technologies to Participate in Upcoming AAAAI 2022 Congress DBV…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage…
ROCKVILLE, Md., Feb. 22, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical…
SPARTA, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the…
RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an…
CAMBRIDGE, Mass., Feb. 22, 2022 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ: SGTX), a biotechnology…
REDWOOD CITY, Calif., Feb. 22, 2022 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…